In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 5th, 2009 | 24 | Yes |
Popular Name: 4-[(2S)-3-(4-benzyl-1-piperidyl)-2-methyl-propyl]phenol 4-[(2S)-3-(4-benzyl-1-piperidyl)…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.99 | 11.78 | -42.38 | 2 | 2 | 1 | 25 | 324.488 | 6 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A-3-E | Alpha-1a Adrenergic Receptor (cluster #3 Of 3), Eukaryotic | Eukaryotes | 92 | 0.41 | Binding ≤ 10μM |
ADA1B-1-E | Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 92 | 0.41 | Binding ≤ 10μM |
ADA1D-1-E | Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 92 | 0.41 | Binding ≤ 10μM |
NMD3A-3-E | Glutamate [NMDA] Receptor Subunit 3A (cluster #3 Of 6), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
NMD3B-3-E | Glutamate [NMDA] Receptor Subunit 3B (cluster #3 Of 6), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
NMDE1-2-E | Glutamate [NMDA] Receptor Subunit Epsilon 1 (cluster #2 Of 5), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
NMDE2-1-E | Glutamate [NMDA] Receptor Subunit Epsilon 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
NMDE3-1-E | Glutamate [NMDA] Receptor Subunit Epsilon 3 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
NMDE4-3-E | Glutamate [NMDA] Receptor Subunit Epsilon 4 (cluster #3 Of 6), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
NMDZ1-2-E | Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 3 | 0.50 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 91.5 | 0.41 | Binding ≤ 1μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 91.5 | 0.41 | Binding ≤ 1μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 91.5 | 0.41 | Binding ≤ 1μM |
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 3.4 | 0.49 | Binding ≤ 1μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 3.4 | 0.49 | Binding ≤ 1μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 3.4 | 0.49 | Binding ≤ 1μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 3.4 | 0.49 | Binding ≤ 1μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 3.4 | 0.49 | Binding ≤ 1μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 3.4 | 0.49 | Binding ≤ 1μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 3.4 | 0.49 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 91.5 | 0.41 | Binding ≤ 10μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 91.5 | 0.41 | Binding ≤ 10μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 91.5 | 0.41 | Binding ≤ 10μM |
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 3.4 | 0.49 | Binding ≤ 10μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 3.4 | 0.49 | Binding ≤ 10μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 3.4 | 0.49 | Binding ≤ 10μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 3.4 | 0.49 | Binding ≤ 10μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 3.4 | 0.49 | Binding ≤ 10μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 3.4 | 0.49 | Binding ≤ 10μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 3.4 | 0.49 | Binding ≤ 10μM |
Description | Species |
---|---|
Adrenoceptors | |
CREB phosphorylation through the activation of CaMKII | |
EPHB-mediated forward signaling | |
G alpha (12/13) signalling events | |
G alpha (q) signalling events | |
Ras activation uopn Ca2+ infux through NMDA receptor | |
Unblocking of NMDA receptor, glutamate binding and activation |